Flex-A-Min Double Strength

Formula re: Contains

GLUCOSAMINE CHONDROITIN FORMULA Plus MSM

Brand IP Statement(s) re: (c), (TM), (SM)

The special ingredients in Flex-a-min(R) Double Strength work together to give your joints the extra support they need.* You can use Flex-a-min(R) Double Strength for your joints daily to cushion, lubricate, and support range of motion all day long.*

Suggested/Recommended/Usage/Directions

Directions: For adults, take three (3) tablets per day, preferably with a meal. Take this product with plenty of fluids. For best results, take the full dosage of Flex-a-min(R) daily, on a continual basis.

Formulation re: Does NOT Contain

No Artificial Flavor or Sweetener, No Preservatives, No Sugar, No Soy, No Gluten, No Wheat, No Yeast.

Precautions re: Pregnant or Nursing or Prescription Medications

WARNING: If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use.

Precautions re: Allergies

Avoid this product if you are allergic to aspirin.

Precautions re: All Other

Discontinue use and consult your doctor if any adverse reactions occur.

Precautions re: Children

Not intended for use by persons under the age of 18. Keep out of reach of children.

Storage

Store at room temperature.

Precautions re: All Other

Do not use if seal under cap is broken or missing.

FDA Disclaimer Statement

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements: All Other Content

3 TABLETS PER DAY!

FDA Statement of Identity

GLUCOSAMINE CHONDROITIN+MSM DIETARY SUPPLEMENT

Formula re: Contains

Contains milk and shellfish (shrimp, crab, lobster, crayfish) ingredients.

Brand IP Statement(s) re: (c), (TM), (SM)

Aflapin(R) is a registered trademark of Laila Nutraceuticals, India. International patents pending.

General: Product/Version Code

Prod. No. 14856 10H B33193

Brand IP Statement(s) re: (c), (TM), (SM)

(C) 2012 Nature’s Bounty, Inc.